Serum cytokine and anti-FcγR autoantibody measurements in patients with systemic sclerosis

Acta Dermato-Venereologica

Volumn 76, Issue 1, 1996, Pages 21-23

  Szegedi, Andrea ^a   Czirják, László ^a   Unkeless, Jay C ^b   Boros, Péter ^c  

^a UNIVERSITY OF DEBRECEN   (Hungary)

^b MOUNT SINAI MEDICAL CENTER   (United States)

^c MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

anti Fc receptor antibody; Interleukin; Scleroderma

Indexed keywords

ALPHA TOCOPHEROL; AUTOANTIBODY; CIMETIDINE; FAMOTIDINE; HISTAMINE H2 RECEPTOR ANTAGONIST; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 2 RECEPTOR; INTERLEUKIN 4; INTERLEUKIN 6; INTERLEUKIN 8; NIFEDIPINE; PENICILLAMINE; PENTOXIFYLLINE; RANITIDINE; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; SYSTEMIC SCLEROSIS;

ANTIBODIES, ANTINUCLEAR; AUTOANTIBODIES; CYTOKINES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FOLLOW-UP STUDIES; HUMANS; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; INTERLEUKINS; MIDDLE AGED; RECEPTORS, IGG; RECEPTORS, INTERLEUKIN-2; SCLERODERMA, SYSTEMIC; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0029670244     PISSN: 00015555     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Kahaleh MB. Soluble immunologie products in scleroderma sera. Clin Immunol Immunopathol 1991; 58: 139-144.
2. Umehara H, Kumagai S, Murakami M, Suginoshita T, Tanaka K, Hashida S, et al. Enhanced production of interleukin-1 and tumor necrosis factor alpha by cultured peripheral blood monocytes from patients with scleroderma. Arthritis Rheum 1990; 33: 893-897.
3. Needleman BW, Wigley FM, Stair RW. Interleukin-1, interleukin-2, interleukin-4, interleukin-6, tumor necrosis factor alpha, and interferon-gamma levels in sera from patients with scleroderma. Arthritis Rheum 1992; 35: 67-72.
4. Kantor TV, Friberg D, Medsger TAJ, Buckingham RB, Whiteside TL. Cytokine production and serum levels in systemic sclerosis. Clin Immunol Immunopathol 1992; 65: 278-285.
5. Clements PJ, Peter JB, Agopian MS, Telian NS, Furst DE. Elevated serum levels of soluble interleukin 2 receptor, interleukin 2 and neopterin in diffuse and limited scleroderma: effects of chlorambucil. J Rheumatol 1990; 17: 908-910.
6. Kahaleh MB, Leroy EC. Interleukin-2 in scleroderma: correlation of serum level with extent of skin involvement and disease duration. Ann Intern Med 1989; 110: 446-450.
7. Famularo G, Procopio A, Giacomelli R, Danese C, Sacchetti S, Perego MA, et al. Soluble interleukin-2 receptor, interleukin-2 and interleukin-4 in sera and supernatants from patients with progressive systemic sclerosis. Clin Exp Immunol 1990; 81: 368-372.
8. Degiannis D, Seibold JR, Czarnecki M, Raskova J, Raska KJ. Soluble interleukin-2 receptors in patients with systemic sclerosis. Clinical and laboratory correlations. Arthritis Rheum 1990; 33: 375-380.
9. Holcombe RF, Baethge BA, Stewart RM, Betzing K, Hall VC, Fukuda M, et al. Cell surface expression of lysosome-associated membrane proteins (LAMPs) in scleroderma: relationship of lamp2 to disease duration, anti-Sc170 antibodies, serum interleukin-8, and soluble interleukin-2 receptor levels. Clin Immunol Immunopathol 1993; 67: 31-39.
10. Romero LI, Pincus SH. In situ localization of interleukin-6 in normal skin and atrophic cutaneous disease. Int Arch Allergy Immunol 1992; 99: 44-49.
11. Reitamo S, Remitz A, Varga J, Ceska M. Effenberger F, Jimenez S, et al. Demonstration of interleukin 8 and autoantibodies to interleukin 8 in the serum of patients with systemic sclerosis and related disorders. Arch Dermatol 1993; 129: 189-193.
12. Zillikens D, Blum C, Dummer R, Hartmann AA, Burg G. Serum levels of soluble interleukin-2 receptor in systemic and circumscribed scleroderma. Dermatology 1992; 184: 233-234.
13. Airo P, Bettinzioli M, Gorla R, Cattaneo R. Increased concentrations of soluble interleukin-2 receptor in the serum of patients with systemic sclerosis. Ann Rheum Dis 1991; 50: 270-271.
14. Boros P, Muryoi T, Spiera H, Bona C, Unkeless JC. Autoantibodies directed against different classes of FcγR are found in sera of autoimmune patients. J Immunol 1993; 150: 2018-2024.
15. Anegon I, Cuturi MC, Trinchieri G, Perussia B. Interaction of Fc receptor (CD16) ligands induces transcription of interleukin 2 receptor (CD25) and lymphokine genes and expression of their products in human natural killer cells. J Exp Med 1988; 167: 452-459.
16. Debets JM, Van De Winkel JG, Ceuppens JL, Dietaren IE, Buurman WA. Cross-linking of both FcγRI and FcγRII induces secretion of tumor necrosis factor by human monocytes, requiring high affinity Fc-FcγR interactions. Functional activation of FcγRII by treatment with proteases or neuraminidase. J Immunol 1990; 144: 1304-1310.
17. Czirjak L, Nagy Z, Szegedi G. Systemic sclerosis in the elderly. Clin Rheumatol 1992; 11: 483-485.
18. Preliminary criteria for the classification of systemic sclerosis (scleroderma). Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee. Arthritis Rheum 1980; 23: 581-590.
19. LeRoy EC, Black C, Fleischmajer R, Jablonska S, Krieg T, Medsger TA Jr, et al. Scleroderma (systemic sclerosis): classification, subsets and pathogenesis. J Rheumatol 1988; 15: 202-205.
20. Boros P, Odin JA, Chen J, Unkeless JC. Specificity and class distribution of FcγR-specific autoantibodies in patients with autoimmune disease. J Immunol 1994; 152: 302-306.
21. Qu Z, Odin JA, Glass JD, Unkeless JC. Expression and characterization of a truncated murine Fcγ receptor. J Exp Med 1988; 167: 1195-1210.
22. Suzuki H, Takemura H, Yoshizaki K, Koishihara Y, Oshugi Y, Okano A, et al. IL-6-anti-IL-6 autoantibody complexes with IL-6 activity in sera from some patients with systemic sclerosis. J Immunol 1994; 152: 935-942.
23. Suzuki H, Ayabe T, Kamimura J, Kashiwagi H. Anti-IL-1 alpha autoantibodies in patients with rheumatic diseases and in healthy subjects. Clin Exp Immunol 1991; 85: 407-412.
24. Szegedi A, Boros P, Chen J, Kaffina M, Bona C, Unkeless JC, An FcγRIII (CD16)-specific autoantibody from a patient with progressive systemic sclerosis. Immunol Lett 1993; 35: 69-76.
25. Boros P, Chen J, Bona C, Unkeless JC. Autoimmune mice make anti-Fcγ receptor Ig. J Exp Med 1990; 171: 1581-1595.